Mr. Andre Godin reports
NEUROBIOPHARM RECEIVES FINAL COURT APPROVAL AND COMPLETES ARRANGEMENT WITH NEPTUNE
NeuroBioPharm Inc., a subsidiary of Neptune Technologies & Bioressources Inc., has completed the previously announced plan of arrangement providing for, among other things, the indirect acquisition by Neptune of all of the issued and outstanding shares of NeuroBio and the issuance by Neptune of 116,714 Class A shares to shareholders of NeuroBio. The Superior Court of Quebec (commercial division) issued a final order on Feb. 16, 2015, approving the arrangement, and all other conditions precedent for the completion of the arrangement are satisfied.
NeuroBio will apply to Canadian securities regulators to cease to be a reporting issuer in each of the provinces and territories of Canada in which it is currently a reporting issuer.
We seek Safe Harbor.
© 2024 Canjex Publishing Ltd. All rights reserved.